US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 0.9826
  • +0.0908+10.18%
Close Feb 14 16:00 ET
  • 1.0000
  • +0.0174+1.77%
Post 20:01 ET
181.25MMarket Cap-1.17P/E (TTM)

About Nektar Therapeutics Company

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Company Profile

SymbolNKTR
Company NameNektar Therapeutics
Listing DateMay 6, 1994
Issue Price7.50
Founded1990
CEOMr. Howard W. Robin
MarketNASDAQ
Employees137
Fiscal Year Ends12-31
Address455 Mission Bay Boulevard South
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-482-5300
Websitehttp://www.nektar.com

Company Executives

  • Name
  • Position
  • Salary
  • Howard W. Robin
  • Director, President and Chief Executive Officer
  • 3.14M
  • Dr. Jonathan Zalevsky, PhD
  • Chief Research and Development Officer
  • 1.77M
  • Sandra A. Gardiner
  • Interim Chief Financial Officer and Principal Accounting Officer
  • 376.30K
  • Mark Andrew Wilson, J.D.
  • Senior Vice President and Chief Legal Officer
  • 1.10M
  • Robert B. Chess
  • Chairman of the Board
  • 176.22K
  • Jeffrey R. Ajer
  • Independent Director
  • 134.22K
  • Dr. Myriam J. Curet, M.D.
  • Independent Director
  • 118.22K
  • Roy A. Whitfield
  • Lead Independent Director
  • 170.22K
  • Dr. Diana M. Brainard, M.D.
  • Independent Director
  • 112.72K
  • R. Scott Greer
  • Independent Director
  • 170.22K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!